05.06.2024 08:19:50 - dpa-AFX: *GILEAD SCIENCES' SELADELPAR SHOWS LONG-TERM EFFICACY, SAFETY IN PRIMARY BILIARY CHOLANGITIS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Gilead Sciences 885823 NASDAQ 66,690 05.07.24 23:14:39 +0,100 +0,15% 66,500 66,690 66,620 66,690

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH